29 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
Settlement Date. The certificates for the Placement Shares, if any, will be made available by the Company for examination and packaging by the Agent … statutes, rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product
8-K
EX-1.1
o6yq5m nlfs0dmn
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
xz8gqxl 83s2zpmvr
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
10-KT
paluqa
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
2yctb mml
7 Oct 15
Prospectus supplement for primary offering
12:00am
10-K
85x7lin7 f8m
29 Sep 14
Annual report
12:00am
10-12G/A
EX-99.1
7mbre lbz5mh65i55nnq
6 Feb 14
Registration of securities (amended)
12:00am